$PTLA News Article - European Commission Grants Conditional Marketing Authorization for Portola Pharmaceuticals' Ondexxya(TM) (andexanet alfa), the First and Only Antidote for the Reversal of Factor Xa Inhibitors
https://marketwirenews.com/news-releases/euro...66946.html